• 13,802Results

  • diagnosis of hypertrophic cardiomyopa

    • Sarcomere Protein Gene Mutations in Hypertrophic ...

      notably, a later age of onset and noncontributory family history. Causes of elderly-onset hypertrophic cardiomyopathy are unknown. Methods and Results—Eighteen women and 13 men diagnosed with late-onset hypertrophic cardiomyopathy were studied. Initial symptoms occurred at 59.3 ( 12.3) years, and diagnosis was made at 62.8 ( 10.8) years.

    • Guidelines for Diagnosis and Treatment of Patients With ...

      clinical studies on the diagnosis and treatment of this disease, especially that on optimal treatment options. In 2002, The Japanese Circulation Society published the “Guidelines for Diagnosis and Treatment of Patients with Hypertrophic Car-diomyopathy” (Chair: Junichi Yoshikawa). In 2007, the guide -

    • Cardiomyopathy: An Overview

      PDF Filehttps://5y1.org/info/diagnosis-of-hypertrophic-cardiomyopa_1_66c612.html

      Patients with hypertrophic cardiomyopa-thy may present with heart failure, although ... and specific in the diagnosis of heart failure in patients with acute dyspnea. One study found that BNP level

    • Management of hypertrophic cardiomyopathy

      PDF Filehttps://5y1.org/info/diagnosis-of-hypertrophic-cardiomyopa_1_d752bd.html

      diagnosis and the present-day pharmacological management of HCM. Key Words: Hypertrophic cardiomyopathy, Genetics, Diagnosis, Pharmacological management, Invasive therapy. Introduction Hypertrophic cardiomyopathy (HCM) is a complex, most common monogenic cardiova-scular disorder that has been at the centre of in-

    • Long-Term Outcomes of Hypertrophic Cardiomyopathy ...

      • The National Australian Childhood Cardiomyopa-thy Study is a long-term national cohort study, with a median follow-up duration of 15 years among surviving subjects. • The greatest risk of death or transplantation for children with hypertrophic cardiomyopathy is in the …

    • Hypertrophic cardiomyopathy: diagnosis, risk ...

      PDF Filehttps://5y1.org/info/diagnosis-of-hypertrophic-cardiomyopa_1_41bf54.html

      prevalence of apical hypertrophic cardiomyopa-thy among East Asian populations, apical involvement is occasionally referred to as Japan-ese hypertrophic cardiomyopathy. However, the skew of prevalence of phenotypes is mild, mak-ing the use of this term misguided.7–9 Hyper-trophic …

    • Diagnosis of apical hypertrophic cardiomyopathy using ...

      PDF Filehttps://5y1.org/info/diagnosis-of-hypertrophic-cardiomyopa_1_d3dcd0.html

      Diagnosis of apical hypertrophic cardiomyopathy using magnetic resonance imaging T Ibrahim, M Schwaiger Abstract Apical hypertrophic cardiomyopathy is an uncommon variant of non-obstructive hypertrophic cardiomyopathy with low prevalence outside East Asia. A case is reported of a non-Asian (European) 51 year old man with characteristic ECG and

    • Prognosis of Hypertrophic Cardiomyopathy

      PDF Filehttps://5y1.org/info/diagnosis-of-hypertrophic-cardiomyopa_1_d6c382.html

      C. Clinical course and prognosis of hypertrophic cardiomyopa-thy in an outpatient population. N Eng J Med 1989; 320:749 - 755. CONCLUSION HCM has a benign prognosis of 1% annual cardiac mortality/year. Echocardiography is obligatory for the diagnosis, follow up and differentiation of the disease from other causes of left ventricular hypertrophy. 44

    • Hypertensive hypertrophic cardiomyopathy or hypertrophic ...

      PDF Filehttps://5y1.org/info/diagnosis-of-hypertrophic-cardiomyopa_1_5b97e8.html

      Of these, 39 patients with both hypertrophic cardiomyopa- thy and systemic hypertension (Group 1) were identified. They ranged in age from 31 to 84 years (mean + SD 60 ? 13); 82% of them were >50 years old. The remaining 74 patients with the diagnosis of hypertrophic cardiomyopathy without

    • 2014 ESC Guidelines on diagnosis and management of ...

      PDF Filehttps://5y1.org/info/diagnosis-of-hypertrophic-cardiomyopa_1_3bf189.html

      2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: web addenda The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) Authors/Task Force Members: Perry M. Elliott* (Chairperson) (UK), Aris Anastasakis

Related searches